Lead Product(s) : Levonorgestrel,Ethinyl Estradiol,Ferrous Bisglycinate
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lupin Launches Minzoya in the US for Contraceptive Use
Details : Minzoya (levonorgestrel and ethinyl estradiol and ferrous bisglycinate Tablets) received approval from the US FDA, it is indicated for use by females of reproductive potential to prevent pregnancy.
Product Name : Minzoya
Product Type : Hormone
Upfront Cash : Inapplicable
January 13, 2025
Lead Product(s) : Levonorgestrel,Ethinyl Estradiol,Ferrous Bisglycinate
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
LOOKING FOR A SUPPLIER?